We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · August 30, 2020

Anti-VEGF Therapy in Diabetic Macular Edema and Visual Acuity Outcomes

Eye (London, England)


Additional Info

Eye (London, England)
An Open-Source Data Set of Anti-VEGF Therapy in Diabetic Macular Oedema Patients Over 4 Years and Their Visual Acuity Outcomes
Eye (Lond) 2020 Jun 26;[EPub Ahead of Print], C Kern, DJ Fu, J Huemer, L Faes, SK Wagner, K Kortuem, PJ Patel, R Rajendram, K Balaskas, R Hamilton, DA Sim, PA Keane

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading